TNF-α INDUCES THROMBOXANE RECEPTOR SIGNALING-DEPENDENT MICROCIRCULATORY DYSFUNCTION IN MOUSE LIVER

McCuskey, 1993, Hepatic microvascular response to endotoxemia and sepsis., Prog Appl Microcirc, 19, 76, 10.1159/000422313

Vollmar, 1996, Modulation of Kupffer cell activity by gadolinium chloride in endotoxemic rats., Shock, 6, 434, 10.1097/00024382-199612000-00008

Chensue, 1991, In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects., Am J Pathol, 138, 395

Luster, 1994, Endotoxin-induced cytokine gene expression and excretion in the liver., Hepatology, 19, 480, 10.1002/hep.1840190229

Essani, 1995, Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure., Hepatology, 21, 1632

Matsumoto, 2002, Effect of FR167653, a novel inhibitor of tumor necrosis factor alpha and interleukin-1 beta synthesis on lipopolysaccharide-induced hepatic microvascular dysfunction in mice., Shock, 17, 411, 10.1097/00024382-200205000-00012

Fox-Robichaud, 2000, Molecular mechanisms of tumor necrosis factor-stimulated leukocyte recruitment into the murine hepatic circulation., Hepatology, 31, 1123, 10.1053/he.2000.6961

Klintman, 2002, Leukocyte recruitment in hepatic injury: selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesion., J Hepatol, 36, 53, 10.1016/S0168-8278(01)00226-4

Ishii, 2002, Neutrophil elastase inhibitor attenuates lipopolysaccharide-induced hepatic microvascular dysfunction in mice., Shock, 18, 163, 10.1097/00024382-200208000-00013

Katagiri, 2004, Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice., Hepatology, 39, 139, 10.1002/hep.20000

Yokoyama, 2005, Role of thromboxane in producing hepatic injury during hepatic stress., Arch Surg, 140, 801, 10.1001/archsurg.140.8.801

Ito, 2008, Leukotriene B4/BLT1 pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxin., Shock, 30, 87, 10.1097/SHK.0b013e31815d06a1

Xu, 2005, Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats., Am J Physiol Gastrointest Liver Physiol, 288, G277, 10.1152/ajpgi.00256.2004

Ishiguro, 1994, : Identification of the thromboxane A2 receptor in hepatic sinusoidal endothelial cells and its role in endotoxin-induced liver injury in rats., Hepatology, 20, 1281, 10.1002/hep.1840200527

Squadrito, 1995, G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-a biosynthesis., Eur J Pharmacol, 286, 31, 10.1016/0014-2999(95)00431-J

Kuhn, 1993, An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophages., Prostaglandins, 46, 195, 10.1016/0090-6980(93)90003-P

Grandel, 2000, : Endotoxin-induced myocardial tumor necrosis factor-a synthesis depresses contractility of isolated rat hearts. Evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production., Circulation, 102, 2758, 10.1161/01.CIR.102.22.2758

Takayama, 2005, : Thromboxane A2 and prostaglandin F2 alpha mediate inflammatory tachycardia., Nat Med, 11, 562, 10.1038/nm1231

Watanabe, 2005, Effects of salt loading on blood pressure in mice lacking the prostanoid receptor gene., Circ J, 69, 124, 10.1253/circj.69.124

Kobayashi, 2004, : Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice., J Clin Invest, 114, 784, 10.1172/JCI200421446

Ichikawa, 1999, Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models., Pharmacology, 59, 257, 10.1159/000028328

Yamamoto, 1996, Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation., Eur J Pharmacol, 314, 137, 10.1016/S0014-2999(96)00537-7

Yamamoto, 1997, FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha, ameliorates endotoxin-induced shock., Eur J Pharmacol, 327, 169, 10.1016/S0014-2999(97)89657-4

Ohtani, 2000, The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats., J Heart Lung Transplant, 19, 377

Decker, 1990, Biologically active products of stimulated liver macrophages (Kupffer cells)., Eur J Biochem, 192, 245, 10.1111/j.1432-1033.1990.tb19222.x

Lee, 1994, : A protein kinase involved in the regulation of inflammatory cytokine biosynthesis., Nature, 372, 739, 10.1038/372739a0

Yokoyama, 2003, Role of thromboxane A2 in early BDL-induced portal hypertension., Am J Physiol Gastrointest Liver Physiol, 284, G453, 10.1152/ajpgi.00315.2002

Narumiya, 2001, Genetic and pharmacological analysis of prostanoid receptor function., J Clin Invest, 108, 25, 10.1172/JCI200113455

Fennekohl, 1999, Differential expression of prostanoid receptors in hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver., J Hepatol, 30, 38, 10.1016/S0168-8278(99)80006-3

Ishizuka, 1996, Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells., Eur J Pharmacol, 312, 367, 10.1016/0014-2999(96)00478-5

Chen, 1994, The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells., Immunol Invest, 23, 269, 10.3109/08820139409066823

Ishizuka, 1998, Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells., Clin Exp Immunol, 112, 464, 10.1046/j.1365-2249.1998.00614.x

Marshall, 2005, Preclinical models of shock and sepsis: what can they tell us?, Shock, 24, 1, 10.1097/01.shk.0000191383.34066.4b